Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Operating Expenses | 1,240 | 690 | 1,046 | 0 |
| Operating Income | -1,240 | -690 | -1,046 | N/A |
| Interest Expense | 1,189 | 778 | 1,380 | 0 |
| Other Income | -2,800 | -727 | -1,466 | 0 |
| Pre-tax Income | -5,229 | -2,196 | -3,891 | 0 |
| Net Income Continuous | -5,229 | -2,196 | -3,891 | N/A |
| Net Income | $-5,229 | $-2,196 | $-3,891 | $N/A |
| EPS Basic Total Ops | -3,241.30 | -10,804.32 | -2,280.91 | N/A |
| EPS Basic Continuous Ops | -3,185.65 | -11,030.05 | -2,244.33 | N/A |
| EPS Diluted Total Ops | -3,241.30 | -10,804.32 | -2,280.91 | N/A |
| EPS Diluted Continuous Ops | -3,185.65 | -11,030.05 | -2,244.33 | N/A |
| EBITDA(a) | $-1,237 | $-683 | $-1,040 | $N/A |